Abingdon, United Kingdom

Gilles Ouvry

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Galderma Holding Sa, Jazz Pharmaceuticals Ireland Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilles Ouvry. Retrieved from https://idiyas.com/inventor/gilles-ouvry-svjkab0d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Gilles Ouvry

Introduction

Gilles Ouvry is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. His work focuses on innovative solutions to treat various diseases and conditions.

Latest Patents

Gilles Ouvry holds a patent for JAK inhibitors and methods for synthesizing and using them. This patent describes novel compounds having formula (I) and outlines methods for using these compounds to treat diseases, conditions, and disorders. His innovative approach has the potential to impact the treatment landscape significantly.

Career Highlights

Ouvry is associated with Galderma Holding SA, a company known for its commitment to dermatological solutions. His role at Galderma has allowed him to contribute to the advancement of medical treatments through his inventive work.

Collaborations

Gilles Ouvry collaborates with Branislav Musicki, enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Gilles Ouvry's contributions to the field of pharmaceuticals through his patent on JAK inhibitors highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…